TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive In Brief: NCI To Work More Closely With Biotherapeutics, DeVita Says; apportionment May Be Abolished February 12, 1988
TCL Archive NIH Director’s Office Funds $106 Million In Cancer Grants With Stimulus Dollars September 18, 2009
TCL Archive Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says August 27, 2004
